Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-009783
Filing Date
2020-03-10
Accepted
2020-03-10 16:55:19
Documents
73
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 2019 10-K snss-10k_20191231.htm 10-K 2542363
2 EX-10.29 snss-ex1029_190.htm EX-10.29 676623
3 EX-21.1 snss-ex211_11.htm EX-21.1 2793
4 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM snss-ex231_10.htm EX-23.1 10724
5 EX-31.1 snss-ex311_8.htm EX-31.1 16532
6 EX-31.2 snss-ex312_6.htm EX-31.2 16750
7 EX-32.1 snss-ex321_7.htm EX-32.1 9824
8 GRAPHIC g4dj111qdu3k000001.jpg GRAPHIC 27867
  Complete submission text file 0001564590-20-009783.txt   9227755

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT snss-20191231.xml EX-101.INS 1721192
10 XBRL TAXONOMY EXTENSION SCHEMA snss-20191231.xsd EX-101.SCH 68888
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20191231_cal.xml EX-101.CAL 60929
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20191231_def.xml EX-101.DEF 196180
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20191231_lab.xml EX-101.LAB 534830
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20191231_pre.xml EX-101.PRE 374162
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 20702462
SIC: 2834 Pharmaceutical Preparations